Commercial Credit Report for Anya Biopharm Inc

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Anya Biopharm Inc is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Anya Biopharm Inc
4F
No.3-2, Yuanqu Street, Nangang District
Phone: +886 226558988p:+886 226558988	TAIPEI, 115 Taiwan	Ticker: 77767776

Business Summary

Anya Biopharm Inc is a Taiwan-based company mainly engaged in the professional biotech and pharmaceutical business. The Company mainly researches and develops oral peptide dosage form platforms and new drug products. The Company has successfully developed the MIRA/JE oral peptide formulation platform and applied it to the lead product ANY002. This drug project has completed early clinical pharmacokinetic trials in animals and humans. ANY002 is a glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of type 2 diabetes and obesity. The Company's oral dosage form, ANY004, is in preclinical development.

(Source: N-30D)

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
6/30/2024	12/31/2023	-	-	-	-	-

Industries

SIC Code	Description
8731	Commercial physical and biological research

General Information

Outstanding Shares:	49,101,520	(As of 10/25/2024)
Stock Exchange:	TPO

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN